Free Trial

agilon health (AGL) to Release Quarterly Earnings on Tuesday

→ The Worst is Yet to Come… (From Porter & Company) (Ad)

agilon health (NYSE:AGL - Get Free Report) is set to release its earnings data after the market closes on Tuesday, May 7th. Analysts expect agilon health to post earnings of ($0.01) per share for the quarter. agilon health has set its FY 2024 guidance at EPS.Persons interested in registering for the company's earnings conference call can do so using this link.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period last year, the company earned ($0.14) EPS. The company's revenue was up 71.8% compared to the same quarter last year. On average, analysts expect agilon health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

agilon health Stock Up 7.1 %

NYSE:AGL traded up $0.37 during trading hours on Tuesday, reaching $5.50. 3,401,766 shares of the stock were exchanged, compared to its average volume of 5,657,024. agilon health has a twelve month low of $4.41 and a twelve month high of $26.75. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a 50 day moving average of $5.49 and a 200 day moving average of $9.20. The stock has a market cap of $2.26 billion, a PE ratio of -8.45 and a beta of 0.49.


Wall Street Analysts Forecast Growth

AGL has been the subject of several recent analyst reports. Leerink Partnrs downgraded agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, January 8th. Wolfe Research downgraded agilon health from an "outperform" rating to a "peer perform" rating in a report on Monday, January 8th. Citigroup initiated coverage on agilon health in a report on Monday, April 22nd. They issued a "neutral" rating and a $6.00 price objective for the company. SVB Leerink downgraded agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, January 8th. Finally, TD Cowen downgraded agilon health from an "outperform" rating to a "market perform" rating and cut their price objective for the company from $12.00 to $6.50 in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $9.46.

Get Our Latest Analysis on agilon health

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Earnings History for agilon health (NYSE:AGL)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Featured Articles and Offers

Search Headlines: